Global Oligonucleotide Pool Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 15667

Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small bits of nucleic acids can be manufactured as single-stranded molecules with any user-specified sequence, and so are vital for artificial gene synthesis, polymerase chain reaction (PCR), DNA sequencing, library construction and as molecular probes.
Oligonucleotide therapeutics have attracted drug manufacturers to guarantee lower drug advancement costs, and the capacity to achieve targets that are not achieved by traditional small molecule drugs. Various clinical candidates have progressed, and a few drugs seem balanced for regulatory approvals. Large pharmaceutical organizations appear to once again investing and putting resources into oligonucleotides through authorizing licensing deals, partnerships, and acquisitions.
In 2018, the global Oligonucleotide Pool market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Oligonucleotide Pool status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oligonucleotide Pool development in United States, Europe and China.

The key players covered in this study
Agilent Technologies
Creative Biogene
CustomArray
Integrated DNA Technologies
MYcroarray
Sigma Aldrich
TriLink BioTechnologies
Twist Bioscience

Market segment by Type, the product can be split into
DNA Pool
RNA Pool

Market segment by Application, split into
Diagnostics
Therapeutics
Research

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Oligonucleotide Pool status, future forecast, growth opportunity, key market and key players.
To present the Oligonucleotide Pool development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Oligonucleotide Pool are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oligonucleotide Pool Market Size Growth Rate by Type (2014-2025)
1.4.2 DNA Pool
1.4.3 RNA Pool
1.5 Market by Application
1.5.1 Global Oligonucleotide Pool Market Share by Application (2014-2025)
1.5.2 Diagnostics
1.5.3 Therapeutics
1.5.4 Research
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Oligonucleotide Pool Market Size
2.2 Oligonucleotide Pool Growth Trends by Regions
2.2.1 Oligonucleotide Pool Market Size by Regions (2014-2025)
2.2.2 Oligonucleotide Pool Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Oligonucleotide Pool Market Size by Manufacturers
3.1.1 Global Oligonucleotide Pool Revenue by Manufacturers (2014-2019)
3.1.2 Global Oligonucleotide Pool Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Oligonucleotide Pool Market Concentration Ratio (CR5 and HHI)
3.2 Oligonucleotide Pool Key Players Head office and Area Served
3.3 Key Players Oligonucleotide Pool Product/Solution/Service
3.4 Date of Enter into Oligonucleotide Pool Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Oligonucleotide Pool Market Size by Type (2014-2019)
4.2 Global Oligonucleotide Pool Market Size by Application (2014-2019)

5 United States
5.1 United States Oligonucleotide Pool Market Size (2014-2019)
5.2 Oligonucleotide Pool Key Players in United States
5.3 United States Oligonucleotide Pool Market Size by Type
5.4 United States Oligonucleotide Pool Market Size by Application

6 Europe
6.1 Europe Oligonucleotide Pool Market Size (2014-2019)
6.2 Oligonucleotide Pool Key Players in Europe
6.3 Europe Oligonucleotide Pool Market Size by Type
6.4 Europe Oligonucleotide Pool Market Size by Application

7 China
7.1 China Oligonucleotide Pool Market Size (2014-2019)
7.2 Oligonucleotide Pool Key Players in China
7.3 China Oligonucleotide Pool Market Size by Type
7.4 China Oligonucleotide Pool Market Size by Application

8 Japan
8.1 Japan Oligonucleotide Pool Market Size (2014-2019)
8.2 Oligonucleotide Pool Key Players in Japan
8.3 Japan Oligonucleotide Pool Market Size by Type
8.4 Japan Oligonucleotide Pool Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Oligonucleotide Pool Market Size (2014-2019)
9.2 Oligonucleotide Pool Key Players in Southeast Asia
9.3 Southeast Asia Oligonucleotide Pool Market Size by Type
9.4 Southeast Asia Oligonucleotide Pool Market Size by Application

10 India
10.1 India Oligonucleotide Pool Market Size (2014-2019)
10.2 Oligonucleotide Pool Key Players in India
10.3 India Oligonucleotide Pool Market Size by Type
10.4 India Oligonucleotide Pool Market Size by Application

11 Central & South America
11.1 Central & South America Oligonucleotide Pool Market Size (2014-2019)
11.2 Oligonucleotide Pool Key Players in Central & South America
11.3 Central & South America Oligonucleotide Pool Market Size by Type
11.4 Central & South America Oligonucleotide Pool Market Size by Application

12 International Players Profiles
12.1 Agilent Technologies
12.1.1 Agilent Technologies Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oligonucleotide Pool Introduction
12.1.4 Agilent Technologies Revenue in Oligonucleotide Pool Business (2014-2019)
12.1.5 Agilent Technologies Recent Development
12.2 Creative Biogene
12.2.1 Creative Biogene Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oligonucleotide Pool Introduction
12.2.4 Creative Biogene Revenue in Oligonucleotide Pool Business (2014-2019)
12.2.5 Creative Biogene Recent Development
12.3 CustomArray
12.3.1 CustomArray Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oligonucleotide Pool Introduction
12.3.4 CustomArray Revenue in Oligonucleotide Pool Business (2014-2019)
12.3.5 CustomArray Recent Development
12.4 Integrated DNA Technologies
12.4.1 Integrated DNA Technologies Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oligonucleotide Pool Introduction
12.4.4 Integrated DNA Technologies Revenue in Oligonucleotide Pool Business (2014-2019)
12.4.5 Integrated DNA Technologies Recent Development
12.5 MYcroarray
12.5.1 MYcroarray Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oligonucleotide Pool Introduction
12.5.4 MYcroarray Revenue in Oligonucleotide Pool Business (2014-2019)
12.5.5 MYcroarray Recent Development
12.6 Sigma Aldrich
12.6.1 Sigma Aldrich Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oligonucleotide Pool Introduction
12.6.4 Sigma Aldrich Revenue in Oligonucleotide Pool Business (2014-2019)
12.6.5 Sigma Aldrich Recent Development
12.7 TriLink BioTechnologies
12.7.1 TriLink BioTechnologies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oligonucleotide Pool Introduction
12.7.4 TriLink BioTechnologies Revenue in Oligonucleotide Pool Business (2014-2019)
12.7.5 TriLink BioTechnologies Recent Development
12.8 Twist Bioscience
12.8.1 Twist Bioscience Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oligonucleotide Pool Introduction
12.8.4 Twist Bioscience Revenue in Oligonucleotide Pool Business (2014-2019)
12.8.5 Twist Bioscience Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details